Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
AIM ImmunoTech Inc. (HEB)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Jun-30-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 |
| | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q |
| Revenues | | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | | 14435.7% | 138.8% | 234.9% | 397.8% | 532.1% | 691.3% | 711.6% |
| Gross profit | | -14335.7% | -38.8% | -134.9% | -297.8% | -432.1% | -591.3% | -611.6% |
| Research and development | | 4992.9% | 5825.4% | 5780.8% | 5238.8% | 5723.9% | 5573.0% | 4742.6% |
| General and administrative | | 9234.3% | 8985.1% | 5937.7% | 6210.8% | 6472.4% | 6857.1% | 6919.4% |
| Depreciation | | 27.1% | 152.2% | 242.5% | 364.7% | 491.8% | 515.1% | 503.9% |
| EBITA | | -14073.6% | -14732.8% | -11747.9% | -11639.6% | -12482.1% | -12923.0% | -12202.3% |
| Amortization of intangibles | | 155.7% | 56.7% | 50.7% | 50.4% | 86.6% | 98.4% | 71.3% |
| EBIT | | -14229.3% | -14789.6% | -11798.6% | -11689.9% | -12568.7% | -13021.4% | -12273.6% |
| Pre-tax income | | -13889.3% | -15598.5% | -12563.7% | -13933.8% | -14273.9% | -13662.7% | -12941.9% |
| Income taxes | | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | | -13889.3% | -15598.5% | -12563.7% | -13933.8% | -14273.9% | -13662.7% | -12941.9% |
|